Wu JJ et al (2015) Inhibition of cGAS DNA sensing by a herpesvirus Virion protein. Cell
Host Microbe 18(3):333–344
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell
144(5):646–674
Hu H et al (2011) Proteomics revisits the cancer metabolome. Expert Rev Proteomics
8(4):505–533
Yogev O et al (2014) Kaposi’s sarcoma herpesvirus microRNAs induce metabolic transfor-
mation of infected cells. PLoS Pathog 10(9):e1004400
Ma T et al (2015) KSHV induces aerobic glycolysis and angiogenesis through HIF-1-dependent
upregulation of pyruvate kinase 2 in Kaposi’s sarcoma. Angiogenesis 18(4):477–488
Zhu Y et al (2016) An oncogenic virus promotes cell survival and cellular transformation by
suppressing glycolysis. PLoS Pathog 12(5):e1005648
Ye F et al (2016) High glucose induces reactivation of latent Kaposi’s sarcoma-associated
herpesvirus. J Virol 90:9654–9663
Sanchez EL et al (2015) Latent KSHV infected endothelial cells are glutamine addicted and
require Glutaminolysis for survival. PLoS Pathog 11(7):e1005052
Delgado T et al (2012) Global metabolic profiling of infection by an oncogenic virus: KSHV
induces and requires lipogenesis for survival of latent infection. PLoS Pathog 8(8):e1002866
Borah S, Verma SC, Robertson ES (2004) ORF73 of herpesvirus saimiri, a viral homolog
of Kaposi’s sarcoma-associated herpesvirus, modulates the two cellular tumor suppressor
proteins p53 and pRb. J Virol 78(19):10336–10347
Cai QL et al (2006) EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for
degradation of the VHL and p53 tumor suppressors. PLoS Pathog 2(10):e116
Cai Q et al (2012) Kaposi’s sarcoma herpesvirus upregulates Aurora A expression to promote
p53 phosphorylation and ubiquitylation. PLoS Pathog 8(3):e1002566
Shin YC et al (2006) Inhibition of the ATM/p53 signal transduction pathway by Kaposi’s
sarcoma-associated herpesvirus interferon regulatory factor 1. J Virol 80(5):2257–2266
Baresova P et al (2014) p53 tumor suppressor protein stability and transcriptional activity
are targeted by Kaposi’s sarcoma-associated herpesvirus-encoded viral interferon regulatory
factor 3. Mol Cell Biol 34(3):386–399
Chang PC, Li M (2008) Kaposi’s sarcoma-associated herpesvirus K-cyclin interacts with
Cdk9 and stimulates Cdk9-mediated phosphorylation of p53 tumor suppressor. J Virol
82(1):278–290
Laura MV et al (2015) KSHV latent protein LANA2 inhibits sumo2 modification of p53. Cell
Cycle 14(2):277–282
Chudasama P et al (2015) Structural proteins of Kaposi’s sarcoma-associated herpesvirus
antagonize p53-mediated apoptosis. Oncogene 34(5):639–649
Lee HR et al (2009) Kaposi’s sarcoma-associated herpesvirus viral interferon regulatory factor
4 targets MDM2 to deregulate the p53 tumor suppressor pathway. J Virol 83(13):6739–6747
Lan K et al (2007) Kaposi’s sarcoma herpesvirus-encoded latency-associated nuclear antigen
stabilizes intracellular activated Notch by targeting the Sel10 protein. Proc Natl Acad Sci U
S A 104(41):16287–16292
Di Bartolo DL et al (2008) KSHV LANA inhibits TGF-beta signaling through epigenetic
silencing of the TGF-beta type II receptor. Blood 111(9):4731–4740
Liang D et al (2014) Oncogenic herpesvirus KSHV Hijacks BMP-Smad1-Id signaling to
promote tumorigenesis. PLoS Pathog 10(7):e1004253
Cannon ML, Cesarman E (2004) The KSHV G protein-coupled receptor signals via mul-
tiple pathways to induce transcription factor activation in primary effusion lymphoma cells.
Oncogene 23(2):514–523
Sodhi A et al (2006) The TSC2/mTOR pathway drives endothelial cell transformation
induced by the Kaposi’s sarcoma-associated herpesvirus G protein-coupled receptor. Cancer
Cell 10(2):133–143
Guo HG et al (2004) Tumorigenesis by human herpesvirus 8 vGPCR is accelerated by human
immunodeficiency virus type 1 Tat. J Virol 78(17):9336–9342